Accuray Incorporated (NASDAQ:ARAY) Short Interest Update

Accuray Incorporated (NASDAQ:ARAY – Get Rating) saw a significant decrease in short interest in February. As of February 28th, there was short interest totalling 4,560,000 shares, a decrease of 5.8% from the February 13th total of 4,840,000 shares. Approximately 5.1% of the shares of the stock are short sold. Based on an average daily volume of 354,800 shares, the short-interest ratio is currently 12.9 days.

Accuray Price Performance

ARAY opened at $2.72 on Thursday. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.82 and a quick ratio of 0.98. The stock has a market capitalization of $259.76 million, a P/E ratio of -20.92 and a beta of 1.51. The company’s 50 day simple moving average is $2.72 and its 200-day simple moving average is $2.33. Accuray has a one year low of $1.70 and a one year high of $3.67.

Accuray (NASDAQ:ARAY – Get Rating) last posted its quarterly earnings data on Wednesday, February 1st. The medical equipment provider reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.01. The firm had revenue of $114.76 million for the quarter, compared to the consensus estimate of $106.28 million. Accuray had a negative return on equity of 23.23% and a negative net margin of 2.83%. Sell-side analysts anticipate that Accuray will post -0.05 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Accuray

Several hedge funds have recently added to or reduced their stakes in ARAY. BlackRock Inc. raised its holdings in Accuray by 1.5% during the 1st quarter. BlackRock Inc. now owns 7,749,993 shares of the medical equipment provider’s stock worth $25,651,000 after purchasing an additional 114,036 shares during the last quarter. Archon Capital Management LLC raised its stake in shares of Accuray by 2.8% during the fourth quarter. Archon Capital Management LLC now owns 6,104,738 shares of the medical equipment provider’s stock worth $12,759,000 after buying an additional 167,747 shares during the last quarter. Neuberger Berman Group LLC raised its stake in shares of Accuray by 8.0% during the third quarter. Neuberger Berman Group LLC now owns 5,246,160 shares of the medical equipment provider’s stock worth $10,905,000 after buying an additional 387,772 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Accuray by 2.7% in the first quarter. Vanguard Group Inc. now owns 4,505,531 shares of the medical equipment provider’s stock valued at $14,913,000 after buying an additional 117,354 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in Accuray by 1.6% in the third quarter. Renaissance Technologies LLC now owns 3,732,175 shares of the medical equipment provider’s stock valued at $7,763,000 after acquiring an additional 60,268 shares during the last quarter. Institutional investors own 63.42% of the company’s stock.

Accuray Company Profile

(Get Rating)

Accuray, Inc is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes CyberKnife and Tomo Therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy.